Mammalian cells contain thousands of metalloproteins and have evolved sophisticated systems for ensuring that metal cofactors are correctly assembled and delivered to their proper destinations. Equally critical in this process are the strategies to avoid the insertion of the wrong metal cofactor into apo-proteins and to avoid the damage that redox-active metals can catalyze in the cellular milieu. Iron and zinc are the most abundant metal cofactors in cells and iron cofactors include heme, iron-sulfur clusters, and mono-and dinuclear iron centers. Systems for the intracellular trafficking of iron cofactors are being characterized. This review focuses on the trafficking of ferrous iron cofactors in the cytosol of mammalian cells, a process that involves specialized iron-binding proteins, termed iron chaperones, of the poly rC-binding protein family.
Introduction
Bioinformatic analyses and high throughput studies of cellular proteins indicate that a large proportion, roughly 30% or more, contain a bound metal cofactor that is required for activity [1] . This reliance on transition metal cofactors is an ancient and conserved property of proteins that appears in all organisms. The requirement for metal ions becomes a biological quandary when one takes into account the work of inorganic biochemists Harry Irving and Robert J. P. Williams, who reported in 1953 that transition metal complexes exhibit a characteristic order of stability, irrespective of the ligand environment, with divalent manganese and iron binding relatively weakly and zinc and copper binding much more tightly [2] This observation would suggest that, given adequate pools of metal ions, cellular metalloproteins would all contain copper ions. Instead, cells contain huge numbers of metalloproteins coordinating a variety of transition metal cations. This variety cannot be explained on the basis of simple stochastic processes in which the appropriate metal ion, free in solution, arrives at its cognate metalloprotein binding site, and is bound based on the affinity of a protein for its native ligand. Instead, cells have evolved systems for distributing and sequestering metal ions that allows for differential metalation.
Work in bacterial systems indicates that prokaryotes express a suite of metal sensors coupled with precisely-buffered intracellular pools of metal ions [3, 4] . Tight-binding metals (copper and zinc) are buffered to exceedingly low concentrations by cytosolic pools of metabolites and macromolecules. Metalation of zinc and copper enzymes is thought to occur through the associative transfer of metal from a buffering ligand to a protein binding site. There is essentially no release of "free" copper or zinc ions into the aqueous cytosol [5] . Weaker-binding metals (iron and manganese) are buffered to higher concentrations and associated with different small and macromolecular ligands [6] . Further control is achieved by selectively transferring metalloproteins and their cognate metals to separate subcellular compartments, for example, the cytosol vs. periplasmic space, where buffered levels of manganese and copper differ and allow selective incorporation of native metals into folding proteins [7] . In eukaryotes, much the same conditions exist, with the added complexity of multiple membrane-bound compartments, each of which may express their own metal uptake and efflux systems.
Studies designed to identify the components of the complex buffer system that maintains metal ions at the appropriate levels have either focused on macromolecular species (proteins) that interact with tightbinding metals, such as metallothioneins, or small molecules that potentially buffer both tight-and weak-binding metals, such as reduced glutathione (GSH), amino acids, and organic acids [8] . GSH has received particular attention, especially with regard to the coordination of ferrous iron [Fe(II)] in eukaryotic cells. A kinetically labile pool of iron has been measured in the cytosol of multiple mammalian cell types at concentrations that range from 1 to 7 μM, with nearly all of this pool being Fe(II) rather than Fe(III) [9] . Speciation plots of Fe(II) and Fe(III) with potential small molecule ligands in cells indicate that, although several molecules, such as ATP, citrate, and cysteine, have significant affinities for either Fe(II) or Fe(III), only GSH is present at sufficiently high concentrations (2-10 mM) in the cell to form complexes with Fethiol in the cysteinyl residue of the GSH tripeptide. The affinity of GSH for manganese is more than 2 orders of magnitude lower than its affinity for iron, the result being that no Mn-GSH complexes are predicted to form in cells. The exclusive formation of Fe(II)-GSH complexes thereby provides a mechanism by which cells may discriminate between these metals for metalation of mono-and diiron centers in nonheme iron enzymes. GSH is required for the assembly of Fe-S clusters in cells and can function as a coordinating ligand for [2Fe-2S] clusters when bound to a glutaredoxin scaffold. Genetic studies in yeast support a primary role for GSH in maintaining iron balance, rather than redox balance [10] .
In prokaryotes and eukaryotes, some metal transfers are accomplished by metallochaperones, which are proteins that bind metals and specifically deliver them directly to targets through protein-protein interactions. In eukaryotes, metallochaperones for copper and iron have been identified [11] [12] [13] . As might be predicted, copper chaperones exhibit a high affinity for copper, specifically interact with only a single or very small number of targets, and transfer copper to targets through a ligand exchange mechanism. Copper-dependent enzymes in eukarytotic cells are relatively few in number; in contrast, iron-containing proteins are very, very abundant [14] . Iron cofactors include heme and iron-sulfur clusters, as well as mononuclear and dinuclear iron centers. Each of these types of cofactors requires a distinct system for synthesis/ assembly and intracellular distribution. Thus, cells would be unlikely to maintain individual, high-specificity iron chaperones to metallate each individual iron protein. Thus far, a single family of iron chaperones has been found to coordinate iron entering the cytosol and to metallate nonheme iron enzymes in mammalian cells, the poly rC-binding proteins (PCBPs) [13, [15] [16] [17] . This review will focus on the trafficking of iron ions within mammalian cells, with particular emphasis on the cytosolic iron ion distribution system and the PCBP family of iron chaperones.
Poly rC binding proteins: multifunctional adaptors
PCBP1 was isolated in a genetic screen designed to identify human proteins that could augment iron loading into the iron storage protein, ferritin, when both were heterologously expressed in yeast [13] . Subsequent studies indicate that other PCBP family members, PCBP2, 3, and 4, also exhibit some iron chaperone activity toward ferritin [16] .
PCBPs are members of the hnRNP K family of RNA binding proteins and have alternatively been referred to as hnRNP E1-E4 and alpha CP-1 and 2. These proteins have a modular structure consisting of three hnRNP Khomology (KH) domains separated by variable linker regions. KH domains are ancient, conserved RNA-and single stranded DNA-binding domains and, in the case of PCBPs, they exhibit preference for binding C-rich oligonucleotides [18] [19] [20] . Binding of PCBPs to RNA affects the fate of the transcript, altering splicing, stability, processing, and translation. PCBPs are also found in complex with other proteins, including other PCBPs, where they can affect the stability and activity of their binding partners. PCBP1 is 83% identical to PCBP2 and both are expressed at high levels in all mammalian cells. In contrast, PCBP3 and PCBP4 exhibit lower homology to PCBP1 and are expressed at very low levels in most cells and tissues. Despite their high similarity, PCBP1 and PCBP2 have distinct functions and bind to distinct RNA and protein species in cells. PCBP1 and PCBP2 bind ferrous iron with low micromolar affinity in a 3 Fe:1 PCBP stoichiometry [21] . They can directly bind ferritin and deliver this iron to ferritin for storage, both in vitro and in vivo. Mammalian Huh7 cells depleted of PCBP1 or PCBP2 exhibit defects in the accumulation of iron into ferritin and cells lacking PCBP1 exhibit increased levels of kinetically labile cytosolic iron [13] . PCBP1 and PCBP2 have distinct roles in the intracellular trafficking of iron, beginning at the uptake of iron across the plasma membrane.
Into the labile iron pool

Iron import into the cytosol
Two pathways contribute towards iron uptake at the plasma membrane and are selective for the two forms of extracellular iron, namely transferrin-bound iron and non-transferrin-bound iron. Under physiological conditions, plasma iron in the form of Fe(III) is tightly bound to apo-transferrin (Tf) in 2:1 ratios resulting in the holo-Tf complex [22] . Holo-Tf binds to transferrin receptor 1 (Tfr1), an integral membrane protein located on the plasma membrane, which triggers endocytosis of the Tf-Tfr1 complex. At the low pH of the endocytotic vesicle, Fe(III) is released from Tf and reduced to Fe(II) by ferrireductases [23] . Divalent metal transporter 1 (DMT1) then transports Fe(II) from the endosome to the cytoplasm [24] . Alternatively, non-transferrin-bound iron may be Fig. 1 . Iron is imported into the cell at the plasma membrane as either non-transferrinbound iron or transferrin-bound iron. Nontransferrin-bound iron is reduced to Fe(II) by ferrireductases at the plasma membrane surface and transported into the cytosol via divalent metal transporter, DMT1, or Zip14. Circulating iron in the form of Fe(III) 2 -transferrin (Tf) binds to transferrin receptor 1 (Tfr1) on the plasma membrane to form Tf-Tfr1 complex, which is endocytosed. At the low pH of the endocytic vesicle, Fe(III) is released from Tf and ferrireductases (e.g., STEAP3) reduce Fe (III) to Fe(II), which is translocated into the cytosol by DMT1. Pcbp1 and Pcbp2 are iron chaperones that bind iron in 1:3 ratio and play integral role in intracellular iron trafficking. Pcbp2 binds iron-loaded DMT1, facilitating iron influx and PCBP2 also binds Fpn1, facilitating iron efflux. Pcbp2 also binds and distributes iron released via heme degradation by heme oxygenases at the endoplasmic reticulum. Fe(II) may be coordinated by reduced glutathione (GSH) in the cytosolic labile iron pool. A significant proportion of the labile iron pool may be coordinated by Pcbp1 and Pcbp2. How Pcbp1 acquires iron has not been experimentally demonstrated; it may come directly from the labile iron pool or via ligand exchange with Pcbp2. Pcbp1 (to a lesser extent, Pcbp2) binds and delivers iron to ferritin and mono-and dinuclear iron proteins. NCOA4 directs ferritin to the lysosome for degradation; from there iron is transported to the mitochondria. The mechanism by which iron is transported from endo-lysosomal compartments to mitochondria is not well understood. Direct transfer of iron from endo-lysosomes to mitochondria may be mediated via DMT1, MCOLN1, and Mnf2. Role of Pcbps in Fe-S cluster formation remains to be studied.
reduced to Fe(II) by ferrireductases at the cell surface and transported into the cytosol by DMT1 or Zip14, a divalent metal transporter of the ZRT/IRT-like Protein family with specificity for zinc, iron and manganese [24, 25] (Fig. 1) .
Recent studies suggest that PCBP2 may be specifically involved in capturing iron as it enters the cytosol from integral membrane transporters and enzymes. Yanatori et al. identified human PCBP2 as a binding partner of DMT1 in a yeast two-hybrid screen performed using a cDNA library generated from human fetal liver. In this screen, they isolated two clones partially encoding PCBP2, both of which contained the KH2 domain and interacted with the amino terminus of DMT1. When full length PCBP1 and PCBP2 were tested for interaction in yeast, only PCBP2 exhibited physical interaction with DMT1, in spite of the sequence similarity between PCBP1 and 2. In order to confirm these results in mammalian systems, the authors performed immunoprecipitation experiments with DMT1 isoforms in Hep-2 cells. All four DMT1 isoforms were found to associate with PCBP2 but not with PCBP1. Cells overexpressing DMT1 in which expression of DMT1 or PCBP2 was subsequently suppressed with RNAi exhibited dramatically (> 90%) reduced uptake of non-transferrin-bound iron. Similar experiments using transferrin-iron demonstrated smaller effects. PCBP2 was found to selectively interact with iron-loaded DMT1. This binding was lost in presence of iron chelators, suggesting the interaction between DMT1 and PCBP2 is iron-dependent. In summary, these studies suggest that PCBP2 specifically functions as a chaperone facilitating iron influx through DMT1 in Hep-2 cells [26] . However, in other studies, depletion of PCBP2 by siRNA in an erythrocyte development model using G1E-ER4 cells [27] or in HEK293T cells [15] did not affect iron uptake or the total level of cellular iron. Instead, G1E-ER4 cells depleted of PCBP2 exhibited increased deposition of iron into ferritin and increased levels of heme and hemoglobin synthesis, indicating that iron uptake into the cytosol was intact. These results suggest that the role of PCBP2 in iron uptake could be cell type specific and additional studies in other cell types would aid in better understanding the roles of chaperones in iron import.
Heme catabolism
Heme from hemoglobin and myoglobin is a major source of dietary iron in mammals that consume meat [28] . More importantly, heme iron, scavenged from senescent red blood cells, is the primary source of iron for the production of new red blood cells in the bone marrow. Red cell heme iron is recycled through erythrophagocytosis, in which macrophages of the reticuloendothelial system engulf aged red blood cells and digest their contents within the erythrophagosome. Heme that is liberated from hemoglobin is transferred across the phagolysosomal membrane to the cytosolic face via the heme transporter HRG1 [29] . Iron is released from heme by the catabolic activity of heme oxygenase (HO). HO degrades heme to biliverdin, carbon monoxide, and ferrous iron, using NADPH-cytochrome P450 reductase (CPR) as a source of electrons [30] . HOs are mainly expressed on the endoplasmic reticulum, where they are anchored by a C-terminal transmembrane domain with the N-terminal catalytic domain facing the cytosol [31, 32] . Mammals express two, separately encoded HOs. HO-1 is the inducible form and HO-2 is constitutively expressed. Both HO-1 and HO-2 play a crucial role in iron utilization, as mice lacking both genes die during embryonic development and mice lacking HO-1 exhibit anemia and tissue iron overload [33] .
Because macrophage HO-1 activity results in the release of large amounts of Fe(II) into the cytosol, Yanatori and colleagues hypothesized that PCBPs might also be involved in the coordination of iron released from HOs [34] . The authors showed that both HO-1 and HO-2 physically interact with PCBP2 in Hep-2 cells. Because HO-1 is regulated by iron levels and plays a greater physiological role in recycling iron from senescent erythrocytes [35] they focused their studies on HO-1. They found that, while PCBP2 binds to HO-1, neither PCBP1, 3 or 4 exhibit binding affinity towards HO-1. Further experiments revealed that the KH3 domain of PCBP2 was essential for the HO-1/PCBP2 interaction. PCBP2 competes with CPR for association with HO-1, as addition of heme or iron preferentially increases HO-1/CPR and decreases HO-1/PCBP2 interaction. Furthermore, iron-loaded PCBP2 loses its HO-1 binding activity. These results suggest that HO-1, CPR and PCBP2 form a functional unit. The authors hypothesize that heme binding to HO-1 causes a conformational change that enables CPR to promote heme degradation and then CPR/HO dissociates and HO associates with PCBP2 and transfers Fe(II) to PCBP2. Iron-loaded PCBP2 then dissociates and transports Fe(II) to effector proteins. Thus, PCBP2 facilitates the capture and distribution of iron that is released via heme degradation.
Out of the labile iron pool
Delivery of iron to ferritin
Initial studies of PCBP1 and PCBP2 indicated that they could function to bind and deliver iron to cytosolic ferritin. Mammalian ferritins are expressed as three distinct peptides: H-ferritin, L-ferritin, and mitochondrial ferritin. In the cytosol, H-and L-ferritin assemble into a cage-like heteropolymer of 24 subunits with a hollow interior into which iron is stored. Ferrous iron binds ferritin and enters the interior through pores formed at the junction of three peptide subunits. These pores form a funnel lined with iron-binding carboxylate side chains which direct the ferrous iron to the interior of the cage [36] . H-ferritin has ferroxidase activity and an active site typical of oxo-bridged diiron monooxygenases. Fe (II) binds in the active site, undergoes oxidation to Fe(III), and is shuttled to interior sites as oxyhydroxides of Fe (III). PCBPs can only interact with the exterior surface of ferritins and thus are presumed to transfer their iron to the pores for transfer to the interior of the ferritin cage [21] .
The importance of this iron transfer from PCBPs to ferritin is evident from studies carried out in models of terminal red blood cell development. Mammalian cells and tissues exhibit widely differing requirements and specialization for iron uptake, utilization, storage, and release. No tissue is more highly specialized for iron flux than the erythron, which in humans takes up 25 mg of iron daily and releases 2 million reticulocytes into the bloodstream per second [37] . When terminal differentiation begins, red cell progenitors massively expand their uptake of transferrin-bound iron from the serum, then transfer the iron to mitochondria for insertion into heme. Heme is then exported to the cytosol, where it is incorporated into nascent globin chains to form hemoglobin. Over the course of a few days, the entire content of the developing red cell becomes a concentrated solution of hemoglobin before release into the circulation as a reticulocyte. This tremendous flux of iron requires precise control of iron acquisition, heme synthesis, and globin production, as imbalances of any component are toxic to the cell [38] .
Ex vivo studies of erythroid development conducted decades ago indicated that iron tends to accumulate in ferritin before the dramatic increase in heme synthesis [39] . More recent studies indicate that PCBP1-mediated iron flux through ferritin is critical for the efficient delivery of iron to the mitochondrion during red cell development [27] .
Using an in vitro model of red cell terminal differentiation, Ryu and colleagues demonstrated that iron taken up via the transferrin receptor pathway is initially stored in ferritin and that PCBP1 is required for this iron storage. PCBP1 binding to ferritin is high in the early stages of terminal differentiation and diminishes in the later stages, indicating that the binding interaction between PCBP1 and ferritin changes during differentiation. Ferritin iron is mobilized for heme synthesis in developing red cells, a process that requires degradation of ferritin in the lysosome and transport of lysosomal iron to the mitochondria. Ferritin is directed to the lysosome by the process of autophagy, which is mediated by the autophagic receptor nuclear coactivator 4 (NCOA4). In the in vitro red cell development model, cells lacking NCOA4 accumulate iron in ferritin and exhibit impaired transfer of iron to mitochondria. Both PCBP1 and NCOA4 are required for efficient heme synthesis, as depletion of either results in lower levels of heme synthesis. Together, these observations indicate that iron flux from the endosome to ferritin and from ferritin to the lysosome, are critical for efficient hemoglobinization of red cells in vitro. Mouse models of PCBP1 or NCOA4 deficiency are associated with anemia and microcytosis, similar to those seen in iron deficiency anemia, confirming the role of iron flux through ferritin in red cell development in vivo.
Both PCBP1-and NCOA4-ferritin binding activities are negatively regulated by cytosolic iron levels [40] . Treatment of developing red cells with supplemental iron causes cytosolic iron to increase and PCBP1-ferritin binding activity to decrease, reducing the delivery of iron to ferritin and likely enhancing ferritin-independent iron delivery to the mitochondria. This effect is reproduced in cell extracts in vitro, suggesting that saturation of iron-binding sites on both PCBP1 and ferritin could account for this effect. Iron regulation of NCOA4 also occurs through direct binding of iron. Purified NCOA4 can directly bind iron in vitro. Iron supplementation in cells triggers the ubiquitinmediated degradation of NCOA4. This process is mediated by the E3-ligase HERC2, which can recognize and ubiquinate the iron-bound form of NCOA4 [40, 41] . When NCOA4 is degraded, ferritin is not directed to the lysosome and is thus stabilized. The net effect of these changes is to reduce the flux of erythrocyte iron through ferritin as cytosolic iron levels rise.
In contrast to its roles in general mammalian cell lines (HEK or Huh7 cells), PCBP2 does not appear to assist in the delivery of iron to ferritin in developing red cells. While PCBP2 is expressed at high levels, it is not detected in complexes with ferritin during red cell differentiation. Surprisingly, depletion of PCBP2 leads to increased, rather than decreased, iron delivery to ferritin and a corresponding increase in heme synthesis. These changes are dependent on the expression of PCBP1, suggesting that PCBP2 influences the iron chaperone activity of PCBP1, perhaps by directing iron-PCBP1 complexes to other targets [27] .
Less is known about the trafficking of iron from endo-lysosomal compartments to mitochondria. A direct transfer of iron from endosomes to mitochondria in circulating reticulocytes has been proposed [42] . DMT1 and an ion channel, MCOLN1, have also been implicated in the transfer of endo-lysosomal iron to mitochondria [43, 44] . The flux of iron from lysosomes to mitochondria may involve a direct transfer, as well, as endolysosomal-mitochondrial contact sites have been observed. Mitofusin 2, a protein involved in mitophagy and mitochondrial fusion, also appears to mediate interactions between mitochondria and other membrane bound compartments. Furthermore, erythroid precursors deleted for mitofusin 2 exhibit lower numbers of lysosomal-mitochondrial contact sites and impaired heme synthesis [43, 45] .
Delivery of iron to non-heme iron enzymes
Iron storage in ferritin is enhanced when cells accumulate iron in excess of their metabolic needs. However, even under conditions of low-iron growth, cells and tissues need iron for metalation of non-heme iron enzymes and PCBP1 and 2 play a role in this process. The simplest iron cofactors are the mono-and dinuclear iron centers of the non-heme iron enzymes. Unlike heme and Fe-S clusters, these iron centers are not dependent on the synthesis or assembly of complex organic or inorganic iron cofactors. Mono-and dinuclear iron enzymes are very abundant in cells and participate in a variety of biosynthetic pathways [46] [47] [48] . The iron centers are typically involved in the activation of oxygen for consumption in dioxygenase or monoxygenase reactions. Because metalation of these iron centers requires Fe(II), which is the iron species bound by PCBPs, and because many of these enzymes are located within the cytosol, as are PCBPs, the role of PCBPs in the metalation of non-heme enzymes was examined.
PCBP1 and PCBP2 are involved in the delivery of iron to the prolyl hydroxylases (PHDs) and asparagyl hydroxylase (FIH1) that trigger the oxygen-dependent degradation of transcription factor HIF1α [17] .
These enzymes are members of the iron and 2-oxoglutarate-dependent dioxygenase family of enzymes and as such contain a mononuclear iron center. In the presence of oxygen, iron, and 2-oxoglutarate, enzymes of this family oxidatively modify a variety of substrates. Prolyl hydroxylation of HIF1α leads to its rapid, ubiquitin-mediated degradation via the proteasome. Depletion of PCBP1 or PCBP2 in human cells reduces PHD activity due to the loss of the iron cofactor. Reduced PHD activity, manifested by reduced prolyl hydroxylation of HIF1α, leads to the stabilization and accumulation of HIF1α. The effects of PCBP depletion on PHD activity are especially prominent in cells made transiently iron deficient, while addition of Fe(II) to cells or to lysates restored PHD activity. Further, affinity capture studies show that PCBP1 physically interacts with PHD2 and FIH1 enzymes. Detection of these interactions in sub-stochiometric ratios suggests that PCBP interactions with client proteins are transient and of low affinity.
Further studies revealed that, in addition to ferritin and mononuclear iron center enzymes, PCBP1 and PCBP2 are involved in the delivery of iron to a dinuclear non-heme iron enzyme [15] . Diiron enzymes are a major class of non-heme iron enzymes that are structurally unrelated to the mononuclear iron enzymes. Frey and colleagues demonstrated that PCBP1 and PCBP2 are required for efficient delivery of iron to deoxyhypusine hydroxylase (DOHH), a dinuclear iron protein that catalyzes the second of two steps in the conversion of a conserved lysine residue to hypusine in eukaryotic initiation factor 5a (eIF5a) [49] . Depletion of PCBP1 or PCBP2 in cells leads to accumulation of partially modified deoxyhypusine and loss of the fully modified hypusine, indicating loss of DOHH activity. Again, the effects of PCBP1 or PCBP2 depletion were especially marked under mild iron deficiency. The DOHH active site contains two Fe(II) ions that form a peroxo bridge upon activation of dioxygen [50] . The apo-and holo-forms of DOHH can be monitored in cells because they exhibit distinct electrophoretic mobilities. PCBP depletion specifically decreases the holo-enzyme, indicating absence of the iron cofactor. In vitro experiments revealed that lysates containing PCBP1 and PCBP2 converted apo-DOHH to holo-DOHH with greater efficiency compared to PCBP1-or PCBP2-depleted lysates. In addition, PCBP1 was found in complex with DOHH in cells treated with supplemental iron, but not in cells made iron deficient [15] .
While iron incorporation into heme exclusively occurs in the mitochondria, Fe-S cluster assembly occurs in both the mitochondrial and cytosolic compartments. Furthermore, mechanisms for the repair of partially degraded Fe-S clusters may exist in the cytosol. Whether PCBPfamily iron chaperones have roles in the delivery of iron for Fe-S cluster assembly or repair remains an open question. Cytosolic aconitase requires a 4Fe-4S cluster for activity. This cluster is chemically labile and vulnerable to oxidative damage. Depletion of either PCBP1 or PCBP2 in Hek293 cells resulted in loss of c-aconitase activity without loss of the c-aconitase protein [15] . The 4Fe-4S cluster of c-aconitase can undergo partial disassembly to a 3Fe-4S cluster or complete disassembly, which leads the enzyme to acquire RNA binding activity. PCBP depletion was accompanied by loss of enzyme activity without acquisition of RNA binding activity, suggesting that PCBPs could be involved in Fe-S cluster repair. Xanthine oxidase contains two stable, solvent-inaccessible 2Fe-2S clusters. PCBP1 or PCBP2 depletion did not affect xanthine oxidase activity in Huh7 cells, even when cells were made iron deficient. In addition, PCBP depletion did not affect mitochondrial iron and heme levels. Thus, PCBPs function as iron chaperones to a number of cytosolic non-heme enzymes especially under low iron conditions and may be involved in delivering iron for Fe-S cluster repair.
Iron export
Ferroportin 1 (FPN1) is the only iron exporter identified in mammalian cells and is expressed mainly on the basolateral membrane of duodenal enterocytes and the plasma membranes of macrophages and hepatocytes [51] [52] [53] [54] [55] . FPN1 transports Fe(II) from the cytosol, across the cellular membrane, into the plasma. Its activity is regulated by hepcidin, a 25-amino acid peptide synthesized by hepatocytes in response to increases in plasma iron [56, 57] . Hepcidin binds to FPN1 and induces its internalization and degradation, thereby decreasing export of iron [58] . Hepcidin-mediated FPN1 regulation is the major mechanism used by mammals to regulate the dietary absorption and release of intracellular iron [59] . However, the mechanism by which FPN1 receives intracellular iron for export is not understood. Previous studies that indicated DMT1 interacts with PCBP2 led investigators to examine the role of PCBPs in FPN1-mediated iron export. Using a yeast two hybrid assay, they found that PCBP2, but not PCBP1, 3 or 4, interacts with FPN1 and validated these results in mammalian Hep-2 cells [60] . Using mutational studies, they also demonstrated that the KH2 domain of PCBP2 binds to the C-terminus of FPN1 in an iron dependent manner. Overexpression of FPN1 in iron-loaded Hep-2 cells lead to enhanced iron efflux, thereby decreasing intracellular iron. Depletion of PCBP2 in cells overexpressing FPN1 attenuated this decrease in iron levels, suggesting that PCBP2 may facilitate the efflux of cytosolic iron through FPN1 by directly delivering iron to the transporter on the plasma membrane.
Conclusion
The work summarized here represents the early stages of investigation into the intracellular trafficking of iron; much remains unexplained. Other proteins and small molecules involved in the iron distribution system likely exist, as do points at which the Fe(II) system interacts with mitochondrial, heme and Fe-S distribution systems. The molecular details of how iron is coordinated and transferred by chaperone proteins needs to be determined. In animals, tissue-specific differences in iron handling and chaperone activity clearly exist and may have important impacts on potential therapeutic agents that perturb or enhance the trafficking of iron in cells.
